RSH 3.57% 2.7¢ respiri limited

Ann: Preliminary Final Report, page-26

  1. 1,268 Posts.
    lightbulb Created with Sketch. 587
    Appreciate your input.
    Yeah sales are the ultimate end result that it needs to be measured on.
    The other endorsements i mentioned above are a key part of any medical products’ journey from “development to sales”. So they need to be ticked off for a product/drug to become part of the “standard of care” is my assumption. Then you can expect meaningful adoption and therefore “sales”.

    So I was just getting a gauge on your thoughts. Thanks again guys.
    Last edited by Yenom23: 27/09/21
 
watchlist Created with Sketch. Add RSH (ASX) to my watchlist
(20min delay)
Last
2.7¢
Change
-0.001(3.57%)
Mkt cap ! $32.10M
Open High Low Value Volume
2.7¢ 2.8¢ 2.7¢ $2.116K 77.79K

Buyers (Bids)

No. Vol. Price($)
1 486755 2.6¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 7799 1
View Market Depth
Last trade - 12.35pm 18/07/2024 (20 minute delay) ?
RSH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.